Impact of dehydroepiandrosterone sulfate and free androgen index on pregnancy and neonatal outcomes in PCOS patients

• Published in: Reproductive biology and endocrinology Vol. 22; no. 1; pp. 43 - 9
• Main Authors: Zhao, Wen, Li, Zeting, Cai, Bing, Zhou, Canquan, Mai, Qingyun
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.04.2024; BioMed Central; BMC
• Subjects: Analysis; Androgens; Care and treatment; Cumulative live birth rates (CLBR); Cumulative pregnancy rates (CPR); Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dehydroepiandrosterone sulfate (DHEAS); Diagnosis; Diseases; Dosage and administration; Female; Free androgen index (FAI); Humans; Infant, Newborn; Infants (Newborn); Male; Morphological variation; Patient outcomes; Polycystic ovary syndrome (PCOS); Polycystic Ovary Syndrome - complications; Pregnancy; Pregnant women; Retrospective Studies; Semen; Stein-Leventhal syndrome; Sulfates; Testosterone; China; Free androgen index (FAI); Cumulative live birth rates (CLBR); Androgens; Cumulative pregnancy rates (CPR); Dehydroepiandrosterone sulfate (DHEAS); Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder associated with infertility and pregnancy complications. The pathogenesis of PCOS and its impact on reproductive function may be influenced by the source of androgens, including testosterone, free androgen, dehydroepiandrosterone sul...